New Recruiting Trial: Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
WHY IT MATTERS
This trial offers a potential new treatment option for heart failure patients who may not respond well to current medications or devices, with enrollment now open at participating sites.
Researchers are testing a new device called synchronized diaphragmatic stimulation to help people with symptomatic heart failure. The diaphragm is the muscle that helps you breathe, and this device stimulates it in a coordinated way to potentially improve how well the heart works. The trial is now accepting patients and is expected to start in April 2026.
NCT ID: NCT06552637 Title: Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure Status: RECRUITING Phase: NA Sponsor: VisCardia Inc. Start date: 2026-04-30 URL: https://clinicaltrials.gov/study/NCT06552637 Source: UniteRare clinical trials database
YOU CAN ACT ON THIS
If you have symptomatic heart failure, check the ClinicalTrials.gov link (NCT06552637) to see if you meet eligibility criteria and find participating sites near you.